drugset / Trial / NCT00325897

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease

NCT00325897

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine if long-term administration of a macrolide antibiotic will reduce worsening of symptoms among individuals with chronic obstructive pulmonary disease (COPD).

Timeline

Start
2006-03
Primary completion
2010-06
Completion
2010-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 250 mg Oral